Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.82
+0.34801.01%
Post-market: 34.820.00000.00%19:30 EDT
Volume:14.09K
Turnover:489.40K
Market Cap:96.80M
PE:- -
High:34.92
Open:34.52
Low:34.42
Close:34.47
52wk High:36.84
52wk Low:23.42
Shares:2.78M
Float Shares:2.78M
Volume Ratio:0.80
T/O Rate:0.51%
Dividend:0.26
Dividend Rate:0.74%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AstraZeneca's Breast Cancer Drug Etcamah Hits A Phase 3 Setback, Clouding Billions In Potential Sales

Options & Short Sell
·
Yesterday

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Stock News
·
6 hours ago

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
9 hours ago

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
9 hours ago

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

TIPRANKS
·
13 hours ago

CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates

Deep News
·
Yesterday

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Yesterday

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Reuters
·
Yesterday

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS
·
Yesterday

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS
·
Yesterday

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS
·
Yesterday

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS
·
Yesterday

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Stock News
·
Yesterday

Market Consolidation with Low Volume: Innovative Drugs Surge Against the Trend, Banking Index Hits New Annual High, Optical Module Leaders Retreat While Capital Seeks Opportunities in High-Optical ETFs

Deep News
·
Yesterday

ETF Market Recap: Short-Term Opportunities Emerge in Previously Corrected Innovative Drug and CXO Sectors Amidst Soft Broader Market Momentum

Deep News
·
Yesterday

Hengrui's Novel Factor XI Monoclonal Antibody Wins NMPA Acceptance for VTE Prevention in Elective Knee Replacement Surgery

Deep News
·
Yesterday

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

Stock News
·
Yesterday

ETF Market Daily Review (09.14) | WCLC Clinical Data Delivers Strong Results, Innovative Drug Sector Rebounds Amid Shifting Computing Power Demand Outlook

Stock News
·
Yesterday

Etcamah Falls Short in Late-Stage Breast Cancer Trial, Clouding AstraZeneca's Sales Outlook for the Drug

Stock News
·
Yesterday

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Yesterday